1133 related articles for article (PubMed ID: 2046748)
1. The p53 tumour suppressor gene.
Levine AJ; Momand J; Finlay CA
Nature; 1991 Jun; 351(6326):453-6. PubMed ID: 2046748
[TBL] [Abstract][Full Text] [Related]
2. p53 mutation heterogeneity in cancer.
Soussi T; Lozano G
Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
[TBL] [Abstract][Full Text] [Related]
3. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
Leung SY; Yuen ST; Chan TL; Chan AS; Ho JW; Kwan K; Fan YW; Hung KN; Chung LP; Wyllie AH
Oncogene; 2000 Aug; 19(35):4079-83. PubMed ID: 10962567
[TBL] [Abstract][Full Text] [Related]
5. Suppressors of the malignant phenotype.
Mikkelsen T; Cavenee WK
Cell Growth Differ; 1990 Apr; 1(4):201-7. PubMed ID: 2128032
[No Abstract] [Full Text] [Related]
6. [Cell cycle, tumor suppressor genes and lung cancers].
Bréchot JM
Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
[TBL] [Abstract][Full Text] [Related]
7. [Cancers, oncogenesis and oncogenes].
Meyer G; Nicoli J
Med Trop (Mars); 1983; 43(3):217-25. PubMed ID: 6350800
[TBL] [Abstract][Full Text] [Related]
8. Oncogenes and their mechanisms of action.
Găldean D
Roum Arch Microbiol Immunol; 1992; 51(1-2):75-99. PubMed ID: 1457825
[No Abstract] [Full Text] [Related]
9. Cancer genetics.
Knudson AG
Am J Med Genet; 2002 Jul; 111(1):96-102. PubMed ID: 12124744
[TBL] [Abstract][Full Text] [Related]
10. p53: balancing tumour suppression and implications for the clinic.
Buganim Y; Rotter V
Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
Spandidos DA
J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
[TBL] [Abstract][Full Text] [Related]
12. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
13. [Cancer and the cell cycle: a current merry-go-round in oncology of clinical relevance].
Fey MF
Schweiz Med Wochenschr; 1998 Apr; 128(16):629-37. PubMed ID: 9611306
[TBL] [Abstract][Full Text] [Related]
14. [P53 protein and human papillomavirus oncogenes in carcinogenesis of the uterine cervix].
Toledo-Cuevas EM; García-Carrancá A
Rev Invest Clin; 1996; 48(1):59-68. PubMed ID: 8815489
[TBL] [Abstract][Full Text] [Related]
15. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
Chang F; Syrjänen S; Kurvinen K; Syrjänen K
Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
[TBL] [Abstract][Full Text] [Related]
16. Human tumor suppressor p53 and DNA viruses.
Collot-Teixeira S; Bass J; Denis F; Ranger-Rogez S
Rev Med Virol; 2004; 14(5):301-19. PubMed ID: 15334538
[TBL] [Abstract][Full Text] [Related]
17. Oncogenes and oncogenesis.
Currie GA
Clin Oncol; 1984 Jun; 10(2):97-101. PubMed ID: 6734013
[No Abstract] [Full Text] [Related]
18. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
19. The p53 tumour suppressor gene.
Steele RJ; Thompson AM; Hall PA; Lane DP
Br J Surg; 1998 Nov; 85(11):1460-7. PubMed ID: 9823903
[TBL] [Abstract][Full Text] [Related]
20. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]